Liven Pharma secures toll manufacturing deal with Skywin

MG News | December 10, 2025 at 10:18 AM GMT+05:00

0:00

December 10, 2025 (MLN): Liven Pharma Limited (PSX:LIVEN) has entered a significant toll manufacturing agreement with Skywin, a strategic step in the company’s long-term growth trajectory.

According to the company’s filing on PSX, the partnership will add two high-value segments to Liven’s product line: hormonal medicines and penicillin-based products.

The company states that this development reflects its commitment to delivering greater value to investors and shareholders.

Liven notes that the expansion represents a bold and aggressive move designed to fuel dynamic growth in the coming years.

At the time of writing, Liven Pharma is being traded at Rs56.1, up Rs0.96 (1.74%).

Copyright Mettis Link News

Related News

Name	Price/Vol	%Chg/NChg
KSE100	151,028.86 97.23M	-2.88% -4482.71
ALLSHR	90,306.06 161.96M	-2.61% -2415.52
KSE30	45,670.68 43.38M	-3.15% -1485.65
KMI30	218,689.46 39.42M	-2.98% -6718.65
KMIALLSHR	59,029.32 95.07M	-2.56% -1547.94
BKTi	41,860.26 14.79M	-3.29% -1426.13
OGTi	31,363.39 4.61M	-3.20% -1036.90

Symbol	Bid/Ask	High/Low

Name	Last	High/Low	Chg/%Chg
BITCOIN FUTURES	66,805.00	68,875.00 66,375.00	-1535.00 -2.25%
BRENT CRUDE	107.73	108.18 99.08	6.57 6.49%
RICHARDS BAY COAL MONTHLY	112.50	0.00 0.00	2.10 1.90%
ROTTERDAM COAL MONTHLY	113.75	116.50 113.75	-5.25 -4.41%
USD RBD PALM OLEIN	1,175.00	1,175.00 1,175.00	0.00 0.00%
CRUDE OIL - WTI	106.16	106.57 97.50	6.04 6.03%
SUGAR #11 WORLD	15.24	15.44 15.05	-0.28 -1.80%